Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sylvamo (SLVM) Cash & Equivalents (2020 - 2025)

Sylvamo (SLVM) has 6 years of Cash & Equivalents data on record, last reported at $135.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 34.15% year-over-year to $135.0 million; the TTM value through Dec 2025 reached $135.0 million, down 34.15%, while the annual FY2025 figure was $135.0 million, 34.15% down from the prior year.
  • Cash & Equivalents reached $135.0 million in Q4 2025 per SLVM's latest filing, up from $94.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $360.0 million in Q4 2022 and bottomed at $94.0 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $178.4 million, with a median of $161.0 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 126.42% in 2022, then tumbled 62.1% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $159.0 million in 2021, then surged by 126.42% to $360.0 million in 2022, then plummeted by 38.89% to $220.0 million in 2023, then fell by 6.82% to $205.0 million in 2024, then tumbled by 34.15% to $135.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $135.0 million in Q4 2025, $94.0 million in Q3 2025, and $113.0 million in Q2 2025.